No CrossRef data available.
Article contents
Cost-effectiveness of clozapine
Published online by Cambridge University Press: 02 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Columns
- Information
- Copyright
- Copyright © 1997 The Royal College of Psychiatrists
References
Aitchison, K. & Kerwin, R. W. (1997) Cost-effectiveness of clozapine. British Journal of Psychiatry, 171, 125–130.CrossRefGoogle ScholarPubMed
Baldessarini, R. J. & Frankenburg, F. R. (1991) Clozapine. A novel antipsychotic agent. New England Journal of Medicine, 324, 746–754.Google ScholarPubMed
Robert, G. & Kennedy, P. (1997) Establishing cost-effectiveness of atypical neuroleptics. British Journal of Psychiatry, 171, 103–104.CrossRefGoogle ScholarPubMed
Umbricht, D. S. G., Lieberman, J. A. & Kane, J. M. (1995) The clinical efficacy of clozapine in the treatment of schizophrenia. Reviews in Contemporary Pharmacotherapy, 6, 165–186.Google Scholar
Wahlbeck, K., Cheine, M., Essali, M. A., et al (1997) Clozapine for schizophrenia. Clozapine versus ‘typical’ neuroleptic medication for schizophrenia. In Schizophrenia Module (eds Adams, C. E., Duggan, L., De Jesus, M. J., et al). The Cochrane Database of Systematic Reviews (available in the Cochrane Library). London: BMJ Publishing.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.